Dariohealth Corp Stock Alpha and Beta Analysis
| DRIO Stock | USD 0.97 0.08 8.99% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as DarioHealth Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in DarioHealth Corp over a specified time horizon. Remember, high DarioHealth Corp's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to DarioHealth Corp's market risk premium analysis include:
Beta 1.09 | Alpha 0.0112 | Risk 4.81 | Sharpe Ratio 0.0267 | Expected Return 0.13 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
DarioHealth |
DarioHealth Corp Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. DarioHealth Corp market risk premium is the additional return an investor will receive from holding DarioHealth Corp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DarioHealth Corp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate DarioHealth Corp's performance over market.| α | 0.01 | β | 1.09 |
DarioHealth Corp expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of DarioHealth Corp's Buy-and-hold return. Our buy-and-hold chart shows how DarioHealth Corp performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.DarioHealth Corp Market Price Analysis
Market price analysis indicators help investors to evaluate how DarioHealth Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DarioHealth Corp shares will generate the highest return on investment. By understating and applying DarioHealth Corp stock market price indicators, traders can identify DarioHealth Corp position entry and exit signals to maximize returns.
DarioHealth Corp Return and Market Media
The median price of DarioHealth Corp for the period between Sat, Aug 10, 2024 and Fri, Nov 8, 2024 is 0.95 with a coefficient of variation of 8.99. The daily time series for the period is distributed with a sample standard deviation of 0.08, arithmetic mean of 0.94, and mean deviation of 0.07. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Erez Raphael of 2000 shares of DarioHealth Corp at 0.89 subject to Rule 16b-3 | 08/16/2024 |
2 | Acquisition by Erez Raphael of 5000 shares of DarioHealth Corp at 0.9 subject to Rule 16b-3 | 08/19/2024 |
3 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.9369 subject to Rule 16b-3 | 08/20/2024 |
4 | Acquisition by Erez Raphael of 5000 shares of DarioHealth Corp at 0.95 subject to Rule 16b-3 | 08/21/2024 |
5 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.945 subject to Rule 16b-3 | 08/22/2024 |
6 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.9499 subject to Rule 16b-3 | 08/23/2024 |
7 | Acquisition by Erez Raphael of 5000 shares of DarioHealth Corp at 0.88 subject to Rule 16b-3 | 08/27/2024 |
8 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8182 subject to Rule 16b-3 | 09/05/2024 |
9 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8401 subject to Rule 16b-3 | 09/06/2024 |
10 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8 subject to Rule 16b-3 | 09/09/2024 |
11 | Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabet... | 09/10/2024 |
12 | Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8045 subject to Rule 16b-3 | 09/11/2024 |
13 | Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes | 09/12/2024 |
14 | Bet on 5 Top-Ranked Stocks With Rising PE for Stellar Gains | 09/18/2024 |
15 | InvestorNewsBreaks DarioHealth Corp. Inks Deal with National Medicare Health Plan to Provide New Digital Mental-Health Benefits for Seniors | 10/01/2024 |
16 | DarioHealth Corp Q2 2024 Earnings Call Highlights Strong B2B2C Growth and Strategic Shifts | 10/09/2024 |
17 | DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th | 10/23/2024 |
18 | DarioHealth Corp. Reports Q3 Loss, Tops Revenue Estimates | 11/07/2024 |
About DarioHealth Corp Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including DarioHealth or other stocks. Alpha measures the amount that position in DarioHealth Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 3.24 | 7.75 | 12.7 | 13.34 | Days Of Inventory On Hand | 137.35 | 161.32 | 128.59 | 93.0 |
DarioHealth Corp Upcoming Company Events
As portrayed in its financial statements, the presentation of DarioHealth Corp's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DarioHealth Corp's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of DarioHealth Corp's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of DarioHealth Corp. Please utilize our Beneish M Score to check the likelihood of DarioHealth Corp's management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with DarioHealth Corp
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out DarioHealth Corp Backtesting, DarioHealth Corp Valuation, DarioHealth Corp Correlation, DarioHealth Corp Hype Analysis, DarioHealth Corp Volatility, DarioHealth Corp History and analyze DarioHealth Corp Performance. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
DarioHealth Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.